Antibiotic Resistance Market Report

Global and Region Antibiotic Resistance Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Jul 30, 2022
  • PAGES：172
  • REPORT CODE：GMM912856
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Antibiotic Resistance market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Antibiotic Resistancemarket, defines the market attractiveness level of Antibiotic Resistance market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Antibiotic Resistance industry, describes the types of Antibiotic Resistance market, the applications of major players and the market size, and deeply analyzes the current situation of the global Antibiotic Resistance market and the development prospects and opportunities of Antibiotic Resistance industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Antibiotic Resistance market in Chapter 13.

    By Player:

    • Macrolide Pharmaceuticals

    • Tetraphase Pharmaceuticals

    • Allergan

    • The Medicines Company

    • BioVersys GmbH

    • Melinta Therapeutics

    • Westway Health

    • AmpliPhi Biosciences

    • Nemesis Bioscience

    • Merck

    • TPfizer

    • Nabriva Therapeutics

    • Phage Technologies SA

    By Type:

    • Urinary Tract Infection

    • Intra-Abdominal Infections

    • Blood Stream Infections

    • Clostridium Difficile Infections

    • Acute Bacterial Skin and Skin Structure Infections

    • Bacterial Pneumonia

    By End-User:

    • Oxazolidinones

    • Lipoglycopeptides

    • Tetracyclines

    • Cephalosporins

    • Combination therapies

    • Other

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Antibiotic Resistance Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Antibiotic Resistance Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Antibiotic Resistance Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Antibiotic Resistance Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Antibiotic Resistance Market Analysis and Outlook to 2022

    • 7.1 Global Antibiotic Resistance Consumption (2017-2022)

    • 7.2 United States Antibiotic Resistance Consumption (2017-2022)

    • 7.3 Europe Antibiotic Resistance Consumption (2017-2022)

    • 7.4 China Antibiotic Resistance Consumption (2017-2022)

    • 7.5 Japan Antibiotic Resistance Consumption (2017-2022)

    • 7.6 India Antibiotic Resistance Consumption (2017-2022)

    • 7.7 South Korea Antibiotic Resistance Consumption (2017-2022)

    8 Region and Country-wise Antibiotic Resistance Market Analysis and Outlook to 2028

    • 8.1 Global Antibiotic Resistance Consumption Forecast (2022-2028)

    • 8.2 United States Antibiotic Resistance Consumption Forecast (2022-2028)

    • 8.3 Europe Antibiotic Resistance Consumption Forecast (2022-2028)

    • 8.4 China Antibiotic Resistance Consumption Forecast (2022-2028)

    • 8.5 Japan Antibiotic Resistance Consumption Forecast (2022-2028)

    • 8.6 India Antibiotic Resistance Consumption Forecast (2022-2028)

    • 8.7 South Korea Antibiotic Resistance Consumption Forecast (2022-2028)

    9 Global Antibiotic Resistance Market Outlook by Types and Applications to 2022

    • 9.1 Global Antibiotic Resistance Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Urinary Tract Infection Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Intra-Abdominal Infections Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Blood Stream Infections Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Clostridium Difficile Infections Consumption and Growth Rate (2017-2022)

      • 9.1.5 Global Acute Bacterial Skin and Skin Structure Infections Consumption and Growth Rate (2017-2022)

      • 9.1.6 Global Bacterial Pneumonia Consumption and Growth Rate (2017-2022)

    • 9.2 Global Antibiotic Resistance Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Oxazolidinones Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Lipoglycopeptides Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Tetracyclines Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global Cephalosporins Consumption and Growth Rate (2017-2022)

      • 9.2.5 Global Combination therapies Consumption and Growth Rate (2017-2022)

      • 9.2.6 Global Other Consumption and Growth Rate (2017-2022)

    10 Global Antibiotic Resistance Market Outlook by Types and Applications to 2028

    • 10.1 Global Antibiotic Resistance Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Urinary Tract Infection Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Intra-Abdominal Infections Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Blood Stream Infections Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.4 Global Clostridium Difficile Infections Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.5 Global Acute Bacterial Skin and Skin Structure Infections Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.6 Global Bacterial Pneumonia Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Antibiotic Resistance Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Oxazolidinones Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Lipoglycopeptides Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Tetracyclines Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.4 Global Cephalosporins Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.5 Global Combination therapies Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.6 Global Other Consumption Forecast and Growth Rate (2022-2028)

    11 Global Antibiotic Resistance Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Antibiotic Resistance Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Antibiotic Resistance Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Antibiotic Resistance Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Antibiotic Resistance Market Competitive Analysis

    • 14.1 Macrolide Pharmaceuticals

      • 14.1.1 Macrolide Pharmaceuticals Company Details

      • 14.1.2 Macrolide Pharmaceuticals Antibiotic Resistance Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Macrolide Pharmaceuticals Antibiotic Resistance Product and Service

    • 14.2 Tetraphase Pharmaceuticals

      • 14.2.1 Tetraphase Pharmaceuticals Company Details

      • 14.2.2 Tetraphase Pharmaceuticals Antibiotic Resistance Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Tetraphase Pharmaceuticals Antibiotic Resistance Product and Service

    • 14.3 Allergan

      • 14.3.1 Allergan Company Details

      • 14.3.2 Allergan Antibiotic Resistance Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Allergan Antibiotic Resistance Product and Service

    • 14.4 The Medicines Company

      • 14.4.1 The Medicines Company Company Details

      • 14.4.2 The Medicines Company Antibiotic Resistance Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 The Medicines Company Antibiotic Resistance Product and Service

    • 14.5 BioVersys GmbH

      • 14.5.1 BioVersys GmbH Company Details

      • 14.5.2 BioVersys GmbH Antibiotic Resistance Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 BioVersys GmbH Antibiotic Resistance Product and Service

    • 14.6 Melinta Therapeutics

      • 14.6.1 Melinta Therapeutics Company Details

      • 14.6.2 Melinta Therapeutics Antibiotic Resistance Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Melinta Therapeutics Antibiotic Resistance Product and Service

    • 14.7 Westway Health

      • 14.7.1 Westway Health Company Details

      • 14.7.2 Westway Health Antibiotic Resistance Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Westway Health Antibiotic Resistance Product and Service

    • 14.8 AmpliPhi Biosciences

      • 14.8.1 AmpliPhi Biosciences Company Details

      • 14.8.2 AmpliPhi Biosciences Antibiotic Resistance Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 AmpliPhi Biosciences Antibiotic Resistance Product and Service

    • 14.9 Nemesis Bioscience

      • 14.9.1 Nemesis Bioscience Company Details

      • 14.9.2 Nemesis Bioscience Antibiotic Resistance Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Nemesis Bioscience Antibiotic Resistance Product and Service

    • 14.10 Merck

      • 14.10.1 Merck Company Details

      • 14.10.2 Merck Antibiotic Resistance Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 Merck Antibiotic Resistance Product and Service

    • 14.11 TPfizer

      • 14.11.1 TPfizer Company Details

      • 14.11.2 TPfizer Antibiotic Resistance Sales, Price, Value and Gross Profit (2017-2022)

      • 14.11.3 TPfizer Antibiotic Resistance Product and Service

    • 14.12 Nabriva Therapeutics

      • 14.12.1 Nabriva Therapeutics Company Details

      • 14.12.2 Nabriva Therapeutics Antibiotic Resistance Sales, Price, Value and Gross Profit (2017-2022)

      • 14.12.3 Nabriva Therapeutics Antibiotic Resistance Product and Service

    • 14.13 Phage Technologies SA

      • 14.13.1 Phage Technologies SA Company Details

      • 14.13.2 Phage Technologies SA Antibiotic Resistance Sales, Price, Value and Gross Profit (2017-2022)

      • 14.13.3 Phage Technologies SA Antibiotic Resistance Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Antibiotic Resistance

    • Figure Antibiotic Resistance Picture

    • Table Global Antibiotic Resistance Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Antibiotic Resistance Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Antibiotic Resistance Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Antibiotic Resistance Consumption by Country (2017-2022)

    • Figure United States Antibiotic Resistance Consumption and Growth Rate (2017-2022)

    • Table Europe Antibiotic Resistance Consumption and Growth Rate (2017-2022)

    • Figure China Antibiotic Resistance Consumption and Growth Rate (2017-2022)

    • Figure Japan Antibiotic Resistance Consumption and Growth Rate (2017-2022)

    • Figure India Antibiotic Resistance Consumption and Growth Rate (2017-2022)

    • Figure South Korea Antibiotic Resistance Consumption and Growth Rate (2017-2022)

    • Figure Global Antibiotic Resistance Consumption Forecast by Country (2022-2028)

    • Figure United States Antibiotic Resistance Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Antibiotic Resistance Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Antibiotic Resistance Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Antibiotic Resistance Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Antibiotic Resistance Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Antibiotic Resistance Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Urinary Tract Infection Consumption and Growth Rate (2017-2022)

    • Figure Global Intra-Abdominal Infections Consumption and Growth Rate (2017-2022)

    • Figure Global Blood Stream Infections Consumption and Growth Rate (2017-2022)

    • Figure Global Clostridium Difficile Infections Consumption and Growth Rate (2017-2022)

    • Figure Global Acute Bacterial Skin and Skin Structure Infections Consumption and Growth Rate (2017-2022)

    • Figure Global Bacterial Pneumonia Consumption and Growth Rate (2017-2022)

    • Figure Global Oxazolidinones Consumption and Growth Rate (2017-2022)

    • Figure Global Lipoglycopeptides Consumption and Growth Rate (2017-2022)

    • Figure Global Tetracyclines Consumption and Growth Rate (2017-2022)

    • Figure Global Cephalosporins Consumption and Growth Rate (2017-2022)

    • Figure Global Combination therapies Consumption and Growth Rate (2017-2022)

    • Figure Global Other Consumption and Growth Rate (2017-2022)

    • Figure Global Urinary Tract Infection Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Intra-Abdominal Infections Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Blood Stream Infections Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Clostridium Difficile Infections Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Acute Bacterial Skin and Skin Structure Infections Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Bacterial Pneumonia Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Oxazolidinones Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Lipoglycopeptides Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Tetracyclines Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Cephalosporins Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Combination therapies Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Other Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Antibiotic Resistance Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Antibiotic Resistance Export by Region (Top 5 Countries) (2017-2028)

    • Table Macrolide Pharmaceuticals (Foundation Year, Company Profile and etc.)

    • Table Macrolide Pharmaceuticals Antibiotic Resistance Sales, Price, Value and Gross Profit (2017-2022)

    • Table Macrolide Pharmaceuticals Antibiotic Resistance Product and Service

    • Table Tetraphase Pharmaceuticals (Foundation Year, Company Profile and etc.)

    • Table Tetraphase Pharmaceuticals Antibiotic Resistance Sales, Price, Value and Gross Profit (2017-2022)

    • Table Tetraphase Pharmaceuticals Antibiotic Resistance Product and Service

    • Table Allergan (Foundation Year, Company Profile and etc.)

    • Table Allergan Antibiotic Resistance Sales, Price, Value and Gross Profit (2017-2022)

    • Table Allergan Antibiotic Resistance Product and Service

    • Table The Medicines Company (Foundation Year, Company Profile and etc.)

    • Table The Medicines Company Antibiotic Resistance Sales, Price, Value and Gross Profit (2017-2022)

    • Table The Medicines Company Antibiotic Resistance Product and Service

    • Table BioVersys GmbH (Foundation Year, Company Profile and etc.)

    • Table BioVersys GmbH Antibiotic Resistance Sales, Price, Value and Gross Profit (2017-2022)

    • Table BioVersys GmbH Antibiotic Resistance Product and Service

    • Table Melinta Therapeutics (Foundation Year, Company Profile and etc.)

    • Table Melinta Therapeutics Antibiotic Resistance Sales, Price, Value and Gross Profit (2017-2022)

    • Table Melinta Therapeutics Antibiotic Resistance Product and Service

    • Table Westway Health (Foundation Year, Company Profile and etc.)

    • Table Westway Health Antibiotic Resistance Sales, Price, Value and Gross Profit (2017-2022)

    • Table Westway Health Antibiotic Resistance Product and Service

    • Table AmpliPhi Biosciences (Foundation Year, Company Profile and etc.)

    • Table AmpliPhi Biosciences Antibiotic Resistance Sales, Price, Value and Gross Profit (2017-2022)

    • Table AmpliPhi Biosciences Antibiotic Resistance Product and Service

    • Table Nemesis Bioscience (Foundation Year, Company Profile and etc.)

    • Table Nemesis Bioscience Antibiotic Resistance Sales, Price, Value and Gross Profit (2017-2022)

    • Table Nemesis Bioscience Antibiotic Resistance Product and Service

    • Table Merck (Foundation Year, Company Profile and etc.)

    • Table Merck Antibiotic Resistance Sales, Price, Value and Gross Profit (2017-2022)

    • Table Merck Antibiotic Resistance Product and Service

    • Table TPfizer (Foundation Year, Company Profile and etc.)

    • Table TPfizer Antibiotic Resistance Sales, Price, Value and Gross Profit (2017-2022)

    • Table TPfizer Antibiotic Resistance Product and Service

    • Table Nabriva Therapeutics (Foundation Year, Company Profile and etc.)

    • Table Nabriva Therapeutics Antibiotic Resistance Sales, Price, Value and Gross Profit (2017-2022)

    • Table Nabriva Therapeutics Antibiotic Resistance Product and Service

    • Table Phage Technologies SA (Foundation Year, Company Profile and etc.)

    • Table Phage Technologies SA Antibiotic Resistance Sales, Price, Value and Gross Profit (2017-2022)

    • Table Phage Technologies SA Antibiotic Resistance Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US